ZM vs. CRSP
ZM (Zoom Video Communications, Inc.) and CRSP (CRISPR Therapeutics AG) are both stocks. ZM operates in Telecom Services (Communication Services), while CRSP operates in Biotechnology (Healthcare). Over the past 5 years, ZM returned -21.27%/yr vs -14.47%/yr for CRSP. At a 0.39 correlation, their price movements are largely independent.
Performance
ZM vs. CRSP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZM achieves a 17.77% return, which is significantly higher than CRSP's -1.14% return.
ZM
- 1D
- -3.41%
- 1M
- -3.34%
- YTD
- 17.77%
- 6M
- 15.94%
- 1Y
- 24.95%
- 3Y*
- 13.50%
- 5Y*
- -21.27%
- 10Y*
- —
CRSP
- 1D
- -8.97%
- 1M
- -5.88%
- YTD
- -1.14%
- 6M
- -8.86%
- 1Y
- 34.40%
- 3Y*
- -7.06%
- 5Y*
- -14.47%
- 10Y*
- —
ZM vs. CRSP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ZM Zoom Video Communications, Inc. | 17.77% | 5.73% | 13.49% | 6.16% | -63.17% | -45.48% | 395.77% | 9.74% |
CRSP CRISPR Therapeutics AG | -1.14% | 33.23% | -37.12% | 54.00% | -46.36% | -50.51% | 151.39% | 67.97% |
Correlation
The correlation between ZM and CRSP is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.40 |
Correlation (All Time) Calculated using the full available price history since Apr 22, 2019 | 0.39 |
The correlation between ZM and CRSP shifts across timeframes, from 0.22 (1 year) to 0.40 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ZM:
$30.51B
CRSP:
$4.98B
ZM:
$6.79
CRSP:
-$6.24
ZM:
6.28
CRSP:
1.15K
ZM:
3.06
CRSP:
2.74
ZM:
$4.93B
CRSP:
$4.10M
ZM:
$3.82B
CRSP:
-$171.17M
ZM:
$1.90B
CRSP:
-$509.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZM vs. CRSP — Risk / Return Rank
ZM
CRSP
ZM vs. CRSP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Zoom Video Communications, Inc. (ZM) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ZM | CRSP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.06 | ||
| Sortino ratioReturn per unit of downside risk | -0.01 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.14 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.03 | 0.82 | +0.21 |
| Martin ratioReturn relative to average drawdown | 2.84 | 1.38 | +1.46 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ZM | CRSP | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.61 | 0.55 | +0.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.48 | -0.24 | -0.24 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.23 | -0.09 |
Drawdowns
ZM vs. CRSP - Drawdown Comparison
The maximum ZM drawdown since its inception was -90.27%, which is greater than CRSP's maximum drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for ZM and CRSP.
Loading charts...
Drawdown Indicators
| ZM | CRSP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.27% | -85.11% | -5.16% |
Max Drawdown (1Y)Largest decline over 1 year | -24.42% | -42.25% | +17.83% |
Max Drawdown (3Y)Largest decline over 3 years | -25.45% | -64.91% | +39.46% |
Max Drawdown (5Y)Largest decline over 5 years | -86.21% | -80.68% | -5.53% |
Current DrawdownCurrent decline from peak | -82.12% | -75.32% | -6.80% |
Average DrawdownAverage peak-to-trough decline | -62.82% | -49.19% | -13.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.99% | 25.06% | -16.07% |
Volatility
ZM vs. CRSP - Volatility Comparison
The current volatility for Zoom Video Communications, Inc. (ZM) is 17.82%, while CRISPR Therapeutics AG (CRSP) has a volatility of 19.12%. This indicates that ZM experiences smaller price fluctuations and is considered to be less risky than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZM | CRSP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.82% | 19.12% | -1.30% |
Volatility (6M)Calculated over the trailing 6-month period | 34.16% | 43.66% | -9.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.30% | 62.97% | -21.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.43% | 60.69% | -16.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.52% | 64.38% | -9.86% |
Dividends
ZM vs. CRSP - Dividend Comparison
Neither ZM nor CRSP has paid dividends to shareholders.
Financials
ZM vs. CRSP - Financials Comparison
This section allows you to compare key financial metrics between Zoom Video Communications, Inc. and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ZM and CRSP have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRSP has higher volatility (19.12%) compared to ZM (17.82%). In terms of maximum drawdown, ZM dropped -90.27% vs CRSP's -85.11%.
ZM currently has the higher Sharpe Ratio (0.61 vs 0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZM and CRSP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer